1
|
Iguchi R, Usui K, Nakayama S, Sasakura Y, Sekiguchi T, Ogasawara M. Multi-regional expression of pancreas-related digestive enzyme genes in the intestinal chamber of the ascidian Ciona intestinalis type A. Cell Tissue Res 2023; 394:423-430. [PMID: 37878073 DOI: 10.1007/s00441-023-03839-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Accepted: 10/17/2023] [Indexed: 10/26/2023]
Abstract
Bilateria share sequential steps in their digestive systems, and digestion occurs in a pre-absorption step within a chamber-like structure. Previous studies on the ascidian Ciona intestinalis type A, an evolutionary research model of vertebrate organs, revealed that Ciona homologs of pancreas-related exocrine digestive enzymes (XDEs) are exclusively expressed in the chamber-like bulging stomach. In the development of the gastrointestinal tract, genes for the pancreas-related transcription factors, namely Ptf1a, Nr5a2, and Pdx, are expressed near the stomach. Recent organ/tissue RNA-seq studies on two Ciona species reported that transcripts of the XDE homologs exist in the intestinal regions, as well as in the stomach. In the present study, we investigated the spatial gene expression of XDE homologs in the gastrointestinal region of the C. intestinalis type A. Whole-mount in situ hybridization using adult and juvenile specimens revealed apparent expression signals of XDE homologs in a small number of gastrointestinal epithelial cells. Furthermore, two pancreas-related transcription factor genes, Nr5a2 and Pdx, exhibited multi-regional expression along the Ciona juvenile intestines. These results imply that ascidians may form multiple digestive regions corresponding to the vertebrate pancreas.
Collapse
Affiliation(s)
- Rin Iguchi
- Department of Biology, Graduate School of Science, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba, 263-8522, Japan
| | - Kanae Usui
- Department of Biology, Graduate School of Science, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba, 263-8522, Japan
| | - Satoshi Nakayama
- Department of Biology, Graduate School of Science, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba, 263-8522, Japan
| | - Yasunori Sasakura
- Shimoda Marine Research Center, University of Tsukuba, 5-10-1 Shimoda, Shizuoka, 415-0025, Japan
| | - Toshio Sekiguchi
- The Noto Marine Laboratory, Division of Marine Environmental Studies, Institute of Nature and Environmental Technology, Kanazawa University, Kanazawa, Housu-gun, Ishikawa, 927-0553, Japan
| | - Michio Ogasawara
- Department of Biology, Graduate School of Science, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba, 263-8522, Japan.
| |
Collapse
|
2
|
Takahashi M, Okada K, Ouch R, Konno T, Usui K, Suzuki H, Satoh M, Kogure T, Satoh K, Watanabe Y, Nakamura H, Murai Y. Fibronectin plays a major role in hypoxia-induced lenvatinib resistance in hepatocellular carcinoma PLC/PRF/5 cells. Pharmazie 2021; 76:594-601. [PMID: 34986955 DOI: 10.1691/ph.2021.1854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Resistance to lenvatinib mesylate (LEN), a systemic chemotherapy that can be administered orally, has been a major issue for treatment of hepatocellular carcinoma (HCC). Although HCC is the tumor that most exhibits intratumoral hypoxia, which has been shown to be involved in the development of treatment resistance, there are no reports of LEN resistance in HCC treatment under hypoxia. The purpose of our study was to elucidate the mechanism of treatment resistance to LEN under hypoxia using HCC cell lines. We confirmed LEN resistance under hypoxic conditions in HCC cell lines. There was a significant increase in the IC50 value of PLC/PRF/5 cells from 13.0±0.8 μM in normoxia to 21.3±1.1 μM in hypoxia, but in HepG2 cells, the increase was not significant. To elucidate the LEN resistance mechanism of PLC/PRF/5 cells under hypoxia, we performed microarray analysis and extracted genes that are thought to be related to this mechanism. Furthermore, in-silico analysis confirmed significant changes in the extracellular matrix, and among them, FN1 encoding fibronectin was determined as the hub of the gene cluster. The expression of fibronectin in PLC/PRF/5 cells examined with immunofluorescence staining was significantly elevated in and outside of cells under hypoxia, and tended to decrease when cells were exposed to LEN under normoxia. Furthermore, the fibronectin concentration in the culture solution of PLC/PRF/5 cells examined by ELISA was 2.3 times higher under hypoxia than under normoxia under LEN(-) conditions, and 1.6 times higher under hypoxia than under normoxia under LEN(+) conditions. It is assumed that in PLC/PRF/5 cells, fibronectin is probably suppressed as an indirect effect of LEN under normoxia, but transcription factors such as HIF-1α are induced under hypoxia, thus enhancing the production of fibronectin and attenuating the effect of LEN, resulting in drug resistance. This behavior of fibronectin with LEN exposure under hypoxia is probably specific to PLC/PRF/5 cells. Further studies should verify the combined effective inhibition of fibronectin and the MAPK pathway as a promising therapeutic strategy to enhance the value of LEN in HCC treatment.
Collapse
Affiliation(s)
- M Takahashi
- Division of Clinical Pharmaceutics, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - K Okada
- Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University; Miyagi, Japan;,
| | - R Ouch
- Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - T Konno
- Division of Clinical Pharmaceutics, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - K Usui
- Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - H Suzuki
- Division of Clinical Pharmaceutics, Tohoku Medical and Pharmaceutical University; Miyagi, Japan; Department of Pharmacy, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - M Satoh
- Division of Gastroenterology, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - T Kogure
- Division of Gastroenterology, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - K Satoh
- Division of Gastroenterology, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - Y Watanabe
- Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - H Nakamura
- Division of Clinical Pharmaceutics, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| | - Y Murai
- Division of Clinical Pharmaceutics, Tohoku Medical and Pharmaceutical University; Miyagi, Japan
| |
Collapse
|
3
|
Usui K, Ogawa K, Goto M, Sakano Y, Shikama N, Kyogoku S, Sasai K, Daida H. Cycle-Generative Adversarial Network-Based Image Correction of 4-Dimensional Cone-Beam Computed Tomography for Lung Cancer Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
4
|
Usui K, Oshima M, Isobe A, Kawamoto T, Shikama N, Sasai K. Analysis of Correlation Between Breast Surface Position and Internal Organ Deformation Using Deep-Inspiration Breath Holding for Left-Sided Breast Irradiation. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
5
|
Hoshino A, Ishikawa N, Tanaka M, Usui K, Komata M, Shizawa M, Katsura T. What lifestyles are risk factors for low well-being of healthy elderlies dwelled in a local city in super-aging Japan? -Kizugawa cohort study. J Rural Med 2020; 15:73-84. [PMID: 32704332 PMCID: PMC7369405 DOI: 10.2185/jrm.2019-015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Accepted: 01/23/2020] [Indexed: 11/27/2022] Open
Abstract
The purpose of this cohort study is to clarify the risk factors of low well-being of elderly people who residing in a local city of a super-aging country, Japan. Subjects are people, who have selected randomly from healthy elderly people resided in Kizugawa City, Kyoto Prefecture, in 2010, followed until 2015. Question survey was conducted in both year, and questionnaire consisted of items such as basic attributes, lifestyles (health practices, consultation behaviors, social activities and so on) and well-being (WHO-5). In analysis we made multi-logistic regression analysis using lifestyle variables as an independent variable and well-being as a dependent variable. The results were as follows. 1. Risk factors were not to exercise, knowledge of appropriate diet, subjective feeling of stress for at least a month, not to participate in voluntary activities, age and bad subjective feeling of health. 2. Risk factors in regard to changes of lifestyles using good-good lifestyles as a reference were sustainment of having no time for hobby or relaxation, sustainment or deterioration of subject feeling of stress for at least a month, sustainment or deterioration of having no time for relaxation and deterioration of having no activities with pleasure or aim. A factor promoting well-being is to have more frequencies for going out home. This study shows that in a longevity society it is important for community-dwelling elderly Japanese to have good health practices, appropriate consultation behaviors and good social activities for the purpose of keeping good well-being, and that these results are contributed to health promotion policy for community-dwelling elderly people.
Collapse
Affiliation(s)
- Akiko Hoshino
- Graduate School of Nursing and Health Sciences, Kyoto Prefectural University of Medicine, Japan
| | - Nobuhito Ishikawa
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Mai Tanaka
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Kanae Usui
- Graduate School of Nursing and Health Sciences, Kyoto Prefectural University of Medicine, Japan
| | - Michiko Komata
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Miho Shizawa
- Graduate School of Nursing and Health Sciences, Kyoto Prefectural University of Medicine, Japan
| | - Toshiki Katsura
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| |
Collapse
|
6
|
Baba K, Tanaka H, Fujita Y, Nakamura A, Kikuchi E, Kawai Y, Harada T, Watanabe N, Yokouchi H, Usui K, Saito R, Watanabe H, Masuda T, Fukuhara T, Kudo K, Honda R, Oizimi S, Maemondo M, Inoue A, Morikawa N. A randomized, phase II study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz437.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Usui K, Isobe A, Hara N, Kawamoto T, Oshima M, Shikama N, Sasai K. Clinical Evaluation of a Rotational Set-up Correction Device for Multiple Brain Metastases Using Single-Isocenter Stereotactic Radiation Therapy. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Katsura T, Abe N, Komata M, Ogura M, Ishikawa N, Hoshino A, Shizawa M, Usui K, Yokoyama E, Hara M. The relationship between the houseboundedness and frailty of community-dwelling elderly persons. J Rural Med 2018; 13:141-150. [PMID: 30546803 PMCID: PMC6288724 DOI: 10.2185/jrm.2972] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Accepted: 07/06/2018] [Indexed: 12/14/2022] Open
Abstract
This study aimed to verify whether the incidence of frailty in elderly individuals is higher among those who are housebound than those who are not. This study found no correlation between elderly people's houseboundedeness and physical, mental, social, and overall frailty. However, the Tilburg Frailty Indicator (TFI) frailty score and grip strength value were higher in non-housebound elderly persons than in housebound elderly ones. This suggests that being housebound may lead to frailty. On the other hand, it is thought that individual interaction with family and friends, and lack of anxiety about falls correlates with the prevention of frailty in housebound elderly persons. The results of the study also suggest that the basic checklist may be effective for ascertaining the actual situation of housebound elderly people who may be manifesting frailty.
Collapse
Affiliation(s)
- Toshiki Katsura
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine Kyoto University, Japan
| | - Narumi Abe
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine Kyoto University, Japan
| | - Michiko Komata
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine Kyoto University, Japan
| | - Mai Ogura
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine Kyoto University, Japan
| | - Nobuhito Ishikawa
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine Kyoto University, Japan
| | - Akiko Hoshino
- Division of Community Health Nursing, Graduate of Nursing and Health Sciences Kyoto Prefectural University of Medicine, Japan
| | - Miho Shizawa
- Division of Community Health Nursing, Graduate of Nursing and Health Sciences Kyoto Prefectural University of Medicine, Japan
| | - Kanae Usui
- Division of Community Health Nursing, Graduate of Nursing and Health Sciences Kyoto Prefectural University of Medicine, Japan
| | | | | |
Collapse
|
9
|
aiba T, Minegishi Y, Yamaguchi O, Kuyama S, Watanabe S, Usui K, Mori M, Hataji O, Nukiwa T, Morita S, Kobayashi K, Gemma A. A phase II study of first-line afatinib for patients aged 75 or older with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan study group trial NEJ027. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Usui K, Yokoyama T, Kisohara A, Mori Y, Takeda Y, Ishida H, Kusano N, Kishi K, Katsushima U, Kuwako T, Aono H, Shikama Y, Minato K, Matsushima H, Uemura K, Ohashi Y, Kunitoh H. The plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Fujimoto M, Katsura T, Hoshino A, Shizawa M, Usui K, Yokoyama E, Hara M. A cohort study on elderly individuals newly certified as requiring long-term care: comparison of rates of care-needs certifications between basic checklist respondents/specific health examinees and non-respondents/non-examinees of 37,000 elderlies in a city. J Rural Med 2018; 13:7-10. [PMID: 29875891 PMCID: PMC5981013 DOI: 10.2185/jrm.2947] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2017] [Accepted: 10/26/2017] [Indexed: 11/27/2022] Open
Abstract
Objective: The rates of care-needs certification were mainly compared
between two cohorts: 7,820 specific health checkup examinees/basic checklist respondents
and 29,234 non-examinees/non-respondents. Subjects and Methods: Among approximately 37,000 elderly citizens of X City,
the number of individuals newly certified as requiring long-term care were observed from
the date of the first specific health checkup in 2008 to March 31, 2013. The aggregated
totals of these individuals and associated factors were evaluated. Results: 1. Support Required 1, Support Required 2, and Long-term Care
Required (level 1) certified individuals accounted for approximately 80% of newly
certified individuals aged 65–74 years. Newly certified individuals aged 75 years and over
had similar results with 37.2% of them being certified Support Required 1, 19.4% certified
Support Required 2, and 22.9% certified Long-term Care Required (level 1). 2. The primary
factors for care-needs certification in individuals aged 65–74 years were arthritic
disorder in 27.6%, falls and bone fractures in 11.3%, and malignant neoplasm and
cerebrovascular disease, among others. This was similar for individuals aged 75 years or
over. 3. Of the 7,820 specific health checkup examinees/basic checklist respondents, 1,280
were newly certified as requiring long-term care (16.4%) compared to 7,878 (26.9%) of the
29,234 non-examinees/non-respondents. Therefore, the latter cohort had a significantly
higher rate of individuals who were newly certified as requiring long-term care. Conclusion: Both specific health checkups and basic checklists are effective
health policies to protect frailty in community elderlies.
Collapse
Affiliation(s)
| | - Toshiki Katsura
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Akiko Hoshino
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | - Miho Shizawa
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | - Kanae Usui
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | | | | |
Collapse
|
12
|
Usui K, Otsuka A, Nakashima C, Katsumoto R, Konishi N, Hayashi M, Kabashima K. 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
13
|
Kondo T, Kuroda S, Usui K, Mori K, Asai T, Takeshima T, Kawahara T, Hamanoue H, Uemura H, Yumura Y. A case of a rare variant of Klinefelter syndrome, 47,XY,i(X)(q10). Andrologia 2018; 50:e13024. [PMID: 29665107 DOI: 10.1111/and.13024] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/08/2018] [Indexed: 11/28/2022] Open
Abstract
Klinefelter syndrome is a condition in which a male patient has one Y chromosome and one or more extra X chromosomes. It is the most common sex chromosome disorder. Klinefelter syndrome is distinguished by many clinical features, such as infertility, high gonadotropin and low testosterone levels, increased height, and sparse body and facial hair. We report the case of a 32-year-old man who visited our hospital complaining of male infertility. Semen analysis showed azoospermia, and chromosomal analysis revealed a 47,XY,i(X)(q10) karyotype, which is a rare variant of Klinefelter syndrome. No spermatozoon was found on microdissection testicular sperm extraction, and the testis biopsy histology showed only Sertoli cells and hyalinised seminiferous tubules. 47,XY, i(X)(q10) has an additional isochromosome made of the long arm of the X chromosome, which shares some features of classical Klinefelter syndrome in many aspects, but patients are usually shorter than average height and have normal intelligence. In addition, to the best of our knowledge, no successful sperm extractions from 47,XY, i(X)(q10) patients were reported in the literature. The reports of patients who have undergone microdissection testicular sperm extraction are very rare. Further reports and studies of this chromosomal abnormality are needed.
Collapse
Affiliation(s)
- T Kondo
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - S Kuroda
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - K Usui
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - K Mori
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - T Asai
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - T Takeshima
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| | - T Kawahara
- Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan
| | - H Hamanoue
- Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Japan
| | - H Uemura
- Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan
| | - Y Yumura
- Department of Urology, Reproduction Center, Yokohama City University Medical Center, Yokohama, Japan
| |
Collapse
|
14
|
Naito T, Yorioka N, Kyuden Y, Yamashita K, Ueda C, Usui K, Shigemoto K, Harada S, Yamakido M. A Case of Antiphospholipid Antibody Syndrome Diagnosed after Thrombosis of an Arteriovenous Shunt. Int J Artif Organs 2018. [DOI: 10.1177/039139889902200804] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A 32-year-old male dialysis patient with lupus nephritis was admitted because of shunt obstruction. The arteriovenous fistula was reconstructed, but obstruction recurred twice within several hours after surgery. A high blood level of anticardiolipin β2-glycoprotein I antibody suggested that shunt obstruction was caused by a thrombotic tendency related to the antiphospholipid antibody syndrome. Accordingly, for the third shunt procedure, antiplatelet therapy (which had been commenced for systemic lupus erythematosus) was combined with dalteparin sodium from before surgery and warfarin was added postoperatively. This regimen prevented shunt obstruction. In conclusion, hemodialysis patients who suffer repeated shunt obstruction should be examined for antiphospholipid antibody syndrome.
Collapse
Affiliation(s)
- T. Naito
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - N. Yorioka
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima City - Japan
| | - Y. Kyuden
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - K. Yamashita
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - C. Ueda
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - K. Usui
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - K. Shigemoto
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - S. Harada
- Ichiyokai Harada Hospital, Hiroshima City - Japan
| | - M. Yamakido
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima City - Japan
| |
Collapse
|
15
|
Taniguchi Y, Yorioka N, Okushin S, Oda H, Usui K, Yamakido M. Usefulness of Immunoadsorption Therapy for Systemic Lupus Erythematosus Associated with Transverse Myelitis. A Case Report. Int J Artif Organs 2018. [DOI: 10.1177/039139889501801209] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Transverse myelitis (TM) is a very rare complication of systemic lupus erythematosus (SLE) and its prognosis is poor. It therefore needs to be treated aggressively. We describe a patient suffering from SLE associated with TM, who responded well to a combination of immunoadsorption therapy and steroid mini-pulse therapy. His serum interleukin 6 levels as well as clinical indicators fell to normal after this treatment.
Collapse
Affiliation(s)
- Y. Taniguchi
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima
| | - N. Yorioka
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima
| | - S. Okushin
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima
| | - H. Oda
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima
| | - K. Usui
- Ichiyokai Harada Hospital, Hiroshima - Japan
| | - M. Yamakido
- Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima
| |
Collapse
|
16
|
Katsura T, Fujimoto M, Shizawa M, Hoshino A, Usui K, Yokoyama E, Hara M. A retrospective cohort study on the risk assessment of newly certificated long-term care need of elderly individuals in a community: Basic checklist and specific health checkup. J Rural Med 2017; 12:68-84. [PMID: 29255523 PMCID: PMC5721290 DOI: 10.2185/jrm.2932] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2017] [Accepted: 05/20/2017] [Indexed: 11/27/2022] Open
Abstract
Objective: This study aimed to examine the factors influencing the
requirement of a certificate of long-term care using a basic checklist and items listed in
the Special Health Checkup. Method: This study included 7,820 individuals living in Uji city, who were
selected from among 8,000 elderly individuals who, in 2008, underwent a specific health
checkup (hereafter referred to as the ‘specific health checkup for the old-old elderly
individuals’) for those aged 75 years and above. They answered questions from basic
checklists at the time, and 180 individuals were excluded as they had already qualified
for requiring the certificate of long-term care at the time of the checkup. The follow-up
period extended from the day of the specific health checkup for the old-old elderly
individuals to March 31, 2013. The data were analyzed using the certificate of needing
long-term care as the response variable. The explanatory variables were the basic
attributes, items listed in the specific health checkup for the old-old elderly
individuals, interview sheets, and basic checklists. Cox proportional hazards regression
analysis was conducted. Results: In total, 1,280 elderly individuals qualified for requiring the
certificate of needing long-term care. The risk factors for the young-old elderly
individuals aged 65 to 74 years were as follows: hepatic dysfunction (hazard ratio
{HR}=1.69), the presence of subjective symptoms (HR=1.41), an above-normal abdominal
circumference (HR=1.36), old age (HR=1.13), a reduced frequency of going out since the
previous year (HR=1.87), the use of support for standing up after being seated on a chair
(HR=1.86), no deposit or withdrawals made (HR=1.84), the anxiety of falling down
(HR=1.50), an inability to climb stairs without holding a railing or wall (HR=1.49), as
well as an increased difficulty in eating tough food items compared with 6 months prior
(HR=1.44). The risk factors for the old-old elderly individuals were as follows: a
positive reaction on proteinuria (HR=1.27), anemia (HR=1.18), old age (HR=1.10), inability
to travel on a bus or train by themselves (HR=1.53), the inability to climb stairs without
holding a railing or wall (HR=1.48), weight loss (HR=1.36), a reduced sense of
appreciation of the activities they had previously participated in, over a span of 2 weeks
(HR=1.30), the use of support for standing up after being seated on a chair (HR=1.23), and
the anxiety of falling down (HR=1.20). Conclusion: The items listed in the specific medical checkup as well as the
basic checklists were found to be risk factors for both the young-old elderly individuals
and the old-old elderly individuals, indicating the need to utilize these lists for the
prevention of nursing even in the late stages of life. Moreover, these results suggest the
importance of screening elderly individuals suffering from hyperkinesis using the basic
checklist and conducting preventive interventions in order to maintain and improve their
physical functions.
Collapse
Affiliation(s)
- Toshiki Katsura
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | | | - Miho Shizawa
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | - Akiko Hoshino
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | - Kanae Usui
- Division of Community Health Nursing, Graduate School of Health and Nursing, Prefectural University of Medicine, Japan
| | | | | |
Collapse
|
17
|
Taniguchi Y, Saihara A, Matsumoto Y, Furukawa R, Ohara S, Sato A, Hojou M, Usui K. P2.03-017 Clinical Features and Treatment with Afatinib in Patients with Squamous Cell Lung Cancer with Sensitive EGFR Mutations. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Usui K, Mori H, Tachi T, Matsumura T, Mori K, Takeda A, Noguchi Y, Yoshimura T, Teramachi H. A rapid method to screen poisoning causative agents in an acute care hospital in Japan. J Clin Pharm Ther 2017; 42:454-460. [DOI: 10.1111/jcpt.12532] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2017] [Accepted: 03/27/2017] [Indexed: 11/30/2022]
Affiliation(s)
- K. Usui
- Laboratory of Clinical Pharmacy; Gifu Pharmaceutical University; Gifu Japan
| | - H. Mori
- Department of Pharmacy; Oogaki Municipal Hospital; Gifu Japan
| | - T. Tachi
- Laboratory of Clinical Pharmacy; Gifu Pharmaceutical University; Gifu Japan
| | - T. Matsumura
- Department of Pharmacy; Oogaki Municipal Hospital; Gifu Japan
| | - K. Mori
- Department of Pharmacy; Oogaki Municipal Hospital; Gifu Japan
| | - A. Takeda
- Department of Pharmacy; Oogaki Municipal Hospital; Gifu Japan
| | - Y. Noguchi
- Laboratory of Clinical Pharmacy; Gifu Pharmaceutical University; Gifu Japan
| | - T. Yoshimura
- Department of Pharmacy; Oogaki Municipal Hospital; Gifu Japan
| | - H. Teramachi
- Laboratory of Clinical Pharmacy; Gifu Pharmaceutical University; Gifu Japan
| |
Collapse
|
19
|
Kawai M, Akino N, Ebisawa N, Grisham L, Hanada M, Honda A, Inoue T, Kazawa M, Kikuchi K, Kuriyama M, Kusanagi N, Mogaki K, Noto K, Ohga T, Ooshima K, Tanai Y, Umeda N, Usui K, Yamamoto T, Yamazaki H, Watanabe K. Progress of Negative Ion Source Improvement in N-NBI for JT-60U. Fusion Science and Technology 2017. [DOI: 10.13182/fst03-a387] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- M. Kawai
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - N. Akino
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - N. Ebisawa
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - L. Grisham
- Princeton Plasma Physics Laboratory, Princeton, NJ, 08543, U.S.A
| | - M. Hanada
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - A. Honda
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - T. Inoue
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - M. Kazawa
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Kikuchi
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - M. Kuriyama
- Vienna Office, Japan Atomic Energy Research Institute, Baumannstrasse 4-2-13, A1030, Wien, Austria 81-29-270-7453
| | - N. Kusanagi
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Mogaki
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Noto
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - T. Ohga
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Ooshima
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - Y. Tanai
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - N. Umeda
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Usui
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - T. Yamamoto
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - H. Yamazaki
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| | - K. Watanabe
- Naka Fusion Research Establishment, Japan Atomic Energy Research Institute, Mukouyama, Naka-machi, Ibaraki-ken, 311-0193, Japan
| |
Collapse
|
20
|
Kuriyama M, Akino N, Ebisawa N, Honda A, Itoh T, Kawai M, Mogaki K, Ohga T, Oohara H, Umeda N, Usui K, Yamamoto M, Yamamoto T, Matsuoka M. Operation and Development on the Positive-Ion Based Neutral Beam Injection System for JT-60 and JT-60U. Fusion Science and Technology 2017. [DOI: 10.13182/fst02-a238] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- M. Kuriyama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - N. Akino
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - N. Ebisawa
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - A. Honda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - T. Itoh
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - M. Kawai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - K. Mogaki
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - T. Ohga
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - H. Oohara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - N. Umeda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - K. Usui
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - M. Yamamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - T. Yamamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-1 Mukohyama, Naka-machi, Naka-gun, Ibaraki-ken, 311-0193 Japan
| | - M. Matsuoka
- University of Mie, Department of Technology Education 1515 Kamihama-cho, Tsu-shi, Japan
| |
Collapse
|
21
|
Akino N, Ebisawa N, Honda A, Ikeda Y, Kawai M, Kazawa M, Mogaki K, Ohga T, Umeda N, Usui K, Yamamoto T, Grisham L. Long Pulse Operation on NBI Systems for JT-60U. Fusion Science and Technology 2017. [DOI: 10.13182/fst05-a777] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- N. Akino
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - N. Ebisawa
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - A. Honda
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Ikeda
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - M. Kawai
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - M. Kazawa
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Mogaki
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Ohga
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - N. Umeda
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Usui
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Yamamoto
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - L. Grisham
- Japan Atomic Energy Resaerch Institute, Naka Fusion Research Establishment, Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| |
Collapse
|
22
|
Kuriyama M, Akino N, Ebisawa N, Grisham L, Honda A, Itoh T, Kawai M, Kazawa M, Mogaki K, Ohara Y, Ohga T, Okumura Y, Oohara H, Umeda N, Usui K, Watanabe K, Yamamoto M, Yamamoto T. Operation and Development of the 500-keV Negative-Ion-Based Neutral Beam Injection System for JT-60U. Fusion Science and Technology 2017. [DOI: 10.13182/fst02-a237] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- M. Kuriyama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - N. Akino
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - N. Ebisawa
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - L. Grisham
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - A. Honda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Itoh
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - M. Kawai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - M. Kazawa
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Mogaki
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Ohara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Ohga
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Okumura
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - H. Oohara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - N. Umeda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Usui
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Watanabe
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - M. Yamamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Yamamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment, 801-1 Mukohyama Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| |
Collapse
|
23
|
Usui K, Inoue T, Kurokawa C, Sugimoto S, Sasai K, Ogawa K. SU-F-J-70: Monte Carlo Study On a Cone-Beam Computed Tomography Using a Cross-Type Carbon Fiber Antiscatter Grid. Med Phys 2016. [DOI: 10.1118/1.4955978] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
24
|
Abstract
AIM In Japan, increasing human longevity has forced society to rethink the notion of what constitutes 'successful ageing'. This study attempts to advocate a new concept of successful ageing that involves complete acceptance of the ageing process. METHOD Research was based on semi-structured interviews with 15 community dwelling oldest-old (aged 85 years and above) participants. The analysis was completed using a grounded theory approach. FINDINGS Successful ageing for the oldest old was grouped into six categories. Within these categories, we discovered the structure of successful ageing, which synthesises ideas from the adaptation process with those of physical and cognitive decreased function as well as spirituality. CONCLUSION The oldest old in Japan work to arrive at a conclusion with their lives, all the while coping with the drawbacks of ageing, such as declining physical and cognitive functions. This resilient and flexible way of life makes their form of ageing an equally 'successful' one.
Collapse
Affiliation(s)
- Michiko Sato-Komata
- PhD Student, Public Health Nursing and Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University
| | - Akiko Hoshino
- Professor in Public Health Nursing, Graduate School of Nursing for Health Care, Kyoto Prefectural University of Medicine
| | - Kanae Usui
- Lecturer in Public Health Nursing, School of Nursing, Kyoto Prefectural University of Medicine
| | - Toshiki Katsura
- Professor in Public Health Nursing and Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| |
Collapse
|
25
|
Tachi T, Yasuda M, Usui K, Umeda M, Nagaya K, Osawa T, Ichihashi A, Noguchi Y, Goto H, Kasahara S, Takahashi T, Goto C, Teramachi H. Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma. Pharmazie 2015; 70:674-677. [PMID: 26601425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Rituximab (RTX), a monoclonal antibody against CD20, is known to cause fewer side effects than conventional anti-cancer drugs; however, infusion reaction (IR), which is specific to monoclonal antibody therapy, is frequently triggered by RTX. Therefore, we designed this study to identify risk factors based on clinical test values for developing IR after RTX administration. Eighty-nine patients with B-cell non-Hodgkin's lymphoma who had received RTX for the first time between February 2010 and March 2013, at the Gifu Municipal Hospital were enrolled as subjects. Analysis of data was conducted for 87 patients, after excluding patients whose data were missing. Univariate analysis showed significant differences in the number of patients exhibiting a soluble interleukin-2 receptor (sLL-2R) level > 2,000 U/L and hemoglobin (Hb) < lower standard limit (LSL) between the IR and non-IR groups. Multivariate analysis showed significant differences with respect to slL-2R > 2,000 U/L [odds ratio (OR), 4.463; 95% confidence interval (Cl), 1.262-15.779; P = 0.020], Hb < LSL [OR, 3.568; 95% CI, 1.071-11.890; P = 0.038], and steroid administration [OR, 0.284; 95% Cl, 0.094-0.852; P = 0.025]. Our findings show that sIL-2R > 2,000 U/L, Hb < LSL, and a lack of steroid premedication are risk factors for developing IR following RTX treatment.
Collapse
|
26
|
Tsukita Y, Morikawa N, Sugawara S, Maemondo M, Harada T, Harada M, Inoue A, Kawashima Y, Fujita Y, Kato T, Yokouchi H, Watanabe H, Usui K, Suzuki T, Oizumi S, Nagai H, Kanbe M, Nukiwa T. Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu355.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
27
|
Sugimoto S, Utsunomiya S, Ebe K, Inoue T, Kurokawa C, Usui K, Sasai K. SU-E-T-465: Dose Calculation Method for Dynamic Tumor Tracking Using a Gimbal-Mounted Linac. Med Phys 2014. [DOI: 10.1118/1.4888798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
28
|
Usui K, Hiroki T, Fujita K, Kabuki S, Kunieda E, Ogawa K. A Study of 4D CBCT Reconstruction Using Detection of the Target Position From 2D Projection Images. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
29
|
Ohashi J, Katsura T, Hoshino A, Usui K. An Analytical Model / Emotional Intelligence Quotient and QOL in Mothers with Infants in Japan. J Rural Med 2013; 8:205-11. [PMID: 25649222 PMCID: PMC4309338 DOI: 10.2185/jrm.2874] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2013] [Accepted: 08/16/2013] [Indexed: 11/27/2022] Open
Abstract
Objective: The purpose of this study was to examine the relationship between
the emotional intelligence quotient and health-related quality of life using structural
equation modeling. Methods: A self-administered questionnaire survey was conducted among 1,911
mothers who visited the Health Center for an infant medical examination. A hypothetical
model was constructed using variables of the emotional intelligence quotient, social
support, coping, parenting stress, and perceived health competence. Result: There were a total of 1,104 valid responses (57.8%). Significant
standardized estimates were obtained, confirming the goodness of fit issues with the
model. The emotional intelligence quotient had a strong impact on physical and
psychological quality of life, and showed the greatest association with coping. This study
differed from previous studies in that, due to the inclusion of social support and
explanatory variables in coping, an increase in coping strategies was more highly
associated with emotional intelligence quotient levels than with social support. Conclusion: An enhanced emotional intelligence quotient should be considered
a primary objective to promote the health of mothers with infant children.
Collapse
Affiliation(s)
- Junko Ohashi
- School of Health and Nursing Sciences, Kansai University of Health Sciences, Japan
| | - Toshiki Katsura
- Department of Preventive Nursing, Graduate School of Medicine, Kyoto University, Japan
| | - Akiko Hoshino
- Graduate School of Nursing for Health Care Science, Kyoto Prefectural University of Medicine, Japan
| | - Kanae Usui
- Graduate School of Nursing for Health Care Science, Kyoto Prefectural University of Medicine, Japan
| |
Collapse
|
30
|
Demura Y, Maemondo M, Ishii Y, Okudera K, Takamura K, Kobayashi K, Morikawa N, Gemma A, Ishimoto O, Harada M, Miura S, Fujita Y, Usui K, Saijo Y. A Phase II Study of Erlotinib Monotherpay in Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Without EGFR Gene Mutation who have Never/Light Smoking History: NEJ006/TCOG0903. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32316-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
31
|
Oizumi S, Inoue A, Sakakibara T, Asahina H, Sugawara S, Maemondo M, Okudera K, Suzuki T, Usui K, Harada M, Morikawa N, Hasegawa Y, Ishimoto O, Nukiwa T. Phase II Study of Amrubicin (AMR) Combined with Carboplatin (CBDCA) for Refractory Relapsed Small Cell Lung Cancer (SCLC): North Japan Lung Cancer Group 0802. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32274-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
32
|
Bae Y, Park Y, Kim J, Han W, Kwak S, Chang Y, Park H, Song N, Yang H, Yoon S, Jeon Y, Hahn S, Lee S, Ko W, England A, Kim W, Oh Y, Kwak J, Kwon M, Chang D, Jeong S, Kim T, Oh B, Jin J, In S, Lee K, Chang D, Watanabe K, Dairaku M, Tobari H, Kashiwagi M, Hanada M, Inoue T, Ikeda Y, Kawai M, Komata M, Mogaki K, Usui K, Yamamoto T, Matsuoka M, Nagaoka K, Grisham L. Commissioning of the first KSTAR neutral beam injection system and beam experiments. Fusion Engineering and Design 2012. [DOI: 10.1016/j.fusengdes.2012.05.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
33
|
Usui K, Ogawa K, Kunieda E. SU-E-J-100: Feasibility of Dose Calculation Using Combined Information of Cone-Beam and Multi-Slice CT Images. Med Phys 2012; 39:3675. [DOI: 10.1118/1.4734936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
34
|
Ohta Y, Nishi S, Haga T, Tsubouchi T, Hasegawa R, Konishi M, Nagano Y, Tsuruwaka Y, Shimane Y, Mori K, Usui K, Suda E, Tsutsui K, Nishimoto A, Fujiwara Y, Maruyama T, Hatada Y. Screening and Phylogenetic Analysis of Deep-Sea Bacteria Capable of Metabolizing Lignin-Derived Aromatic Compounds. ACTA ACUST UNITED AC 2012. [DOI: 10.4236/ojms.2012.24021] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
35
|
Katsura T, Miura N, Hoshino A, Usui K, Takahashi Y, Hisamoto S. Visual recognition of the elderly concerning risks of falling or stumbling indoors in the home: -comparison of visual attention points among elderly, middle aged and young individuals-. J Rural Med 2011; 6:71-80. [PMID: 25648876 PMCID: PMC4309355 DOI: 10.2185/jrm.6.71] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2011] [Accepted: 10/21/2011] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE The objective of this study was to verify the recognition of dangers and obstacles within a house in the elderly when walking based on analyses of gaze point fixation. MATERIALS AND METHODS The rate of recognizing indoor dangers was compared among 30 elderly, 14 middle-aged and 11 young individuals using the Eye Mark Recorder. RESULTS 1) All of the elderly, middle-aged and young individuals showed a high recognition rate of 100% or near 100% when ascending outdoor steps but a low rate of recognizing obstacles placed on the steps. They showed a recognition rate of about 60% when descending steps from residential premises to the street. The rate of recognizing middle steps in the elderly was significantly lower than that in younger and middle-aged individuals. Regarding recognition indoors, when ascending stairs, all of the elderly, middle-aged and young individuals showed a high recognition rate of nearly 100%. When descending stairs, they showed a recognition rate of 70-90%. However, although the recognition rate in the elderly was lower than in younger and middle-aged individuals, no significant difference was observed. 2) When moving indoors, all of the elderly, middle-aged and young individuals showed a recognition rate of 70%-80%. The recognition rate was high regarding obstacles such as floors, televisions and chests of drawers but low for obstacles in the bathroom and steps on the path. The rate of recognizing steps of doorsills forming the division between a Japanese-style room and corridor as well as obstacles in a Japanese-style room was low, and the rate in the elderly was low, being 40% or less. CONCLUSION The rate of recognizing steps of doorsills as well as obstacles in a Japanese-style room was lower in the elderly in comparison with middle-aged or young individuals.
Collapse
Affiliation(s)
- Toshiki Katsura
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Norio Miura
- National Institute of Technology and Evaluation (NITE), Japan
| | - Akiko Hoshino
- Graduate School of Nursing, Kyoto Prefectural University of Medicine, Japan
| | - Kanae Usui
- Division of Preventive Nursing, Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | | | | |
Collapse
|
36
|
Hoshino A, Usui K, Katsura T. The development of a town of safety, security and health project in an area with a very high population aging rate: -the activities of a community salon on a shopping street and their assessment-. J Rural Med 2011; 6:65-70. [PMID: 25648536 PMCID: PMC4309352 DOI: 10.2185/jrm.6.65] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2011] [Accepted: 10/21/2011] [Indexed: 11/27/2022] Open
Abstract
Objective: The aim of this study was to assess the “Health Care Town in
Kyoto” project designed to promote health and safety for health conscious people in a
small community. We conducted a survey involving the users of the salon and local
residents to examine the effects of the activities in the salon. Methods: We recorded the activities of salon and conducted semi-structured
interviews with ten local residents to ask their opinions about the salon. The data from
the interviews were analyzed using the Grounded Theory Approach. We distributed a
questionnaire and collected 215 valid responses (valid response rate: 67.8%). Results: 1) Purpose of using the salon was categorized into health
consultation, conversation with others, rest and other purpose. 2) The significance of the
salon for users was categorized into usability, acquisition of useful information, changes
in daily habits and their maintenance, diversion, interaction with other people and
acceptance by the shopping center. 3) The results of the questionnaire survey showed
marked relations between Well-Being Index (WHO-5), age, employment and family budget,
self-rated health and ability to perform daily activities (TMIG), whereas use of the salon
was not associated with Well-Being Index (WHO-5). On the other hand, there were marked
relations between loneliness (LSO), educational background and use of the salon,
demonstrating that the facility helped its users reduce loneliness (LSO). Conclusion: In this town, the salon has served as a place providing
effective preventive support for the health of individual users.
Collapse
Affiliation(s)
- Akiko Hoshino
- Graduate School of Nursing, Kyoto Prefectural University of Medicine, Japan
| | - Kanae Usui
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| | - Toshiki Katsura
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Japan
| |
Collapse
|
37
|
Thornhill A, Wheat S, Al-Shenar S, Atalla N, Menabawey M, Summers M, Giles J, Vidal C, Alama P, Bosch E, Zuzuarregui JL, Pellicer A, Nelen WLDM, den Breejen EME, Schol SFE, Kremer JAM, Hermens RPMG, Nagai R, Fukunaga N, Kitasaka H, Yoshimura T, Itoi F, Tamura F, Kitamura K, Hasegawa N, Kato M, Nakayama K, Honma H, Oguri H, Sano M, Hashiba Y, Asada Y, den Breejen EME, Hermens RPMG, Galama WH, Willemsen WN, Nelen WLDM, Kremer JAM, Lashwood A, Solomonides A, Olive M, Harton G, Patch C, Flinter F, Mendoza R, Perez S, de los Santos MJ, Larreategui Z, Exposito A, Aparicio MV, Martinez Indart L, Matorras R, Sato Y, Nakamura Y, Sakamoto E, Tasaka A, Usui K, Hattori H, Ito Y, Nakajo Y, Doshida M, Kyono K, Koike A, Haruki A, Horiuchi R, Sugihara K, Fukuda A, Morimoto Y, Cambiaghi A, Leao R, Castellotti D, Nascimento P, Molina Gonzalez I, Clavero Gilabert A, Gonzalvo Lopez MC, Rosales Martinez A, Martinez Navarro L, Mozas Moreno J, Castilla Alcala JA, Fleischer K, Muller AF, Hohmann FP, de Jong FH, Eijkemans MJC, Fauser BC, Laven JSE, Bonduelle M, Van Landuyt L, Stoop D, Van de Velde H, Verheyen G, Haentjens P, Desmyttere S, Carlos RV, Setti AS, Braga DPAF, Figueira RCS, Iaconelli Jr. A, Borges Jr. E, Bariani F, Vespasiano F, Puoti F, Fehily D, Porta E, Nanni Costa A, Zhang Y, Cui Y, Wang L, Zhao H, Zhao W, Wang J, Gao L, Sha J, Zhou Z, Liu J, Liu W, Li XF, Xi WY, Tan L, Fan LQ, Lu GX, Bungum M, Bungum L, Lynch KF, Wedlund L, Humaidan P, Giwercman A, Godunova V, Kaulins T, Godunovs K, Jonina I, Pozilenkova N, Subnikovs N, Trejs G, Lejins V, Mohova M, Rumjanceva I, Arajs M. POSTER VIEWING SESSION - QUALITY AND SAFETY OF ART THERAPIES. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Kinoshita M, Mitsueda-Ono T, Hitomi T, Taki J, Usui K, Matsuhashi M, Matsumoto R, Mikuni N, Fukuyama H, Takahashi R, Ikeda A. P16-9 Change in cortical fast activities after high frequency electric cortical stimulation in a patient with cortical dysplasia and intractable epilepsy. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60816-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
39
|
Kyono K, Doshida M, Toya M, Usui K, Ishikawa T, Sankai T, Owada N. 27 NEW FREEZING METHOD BY PULSED MAGNETIC FIELD EFFECTS; WHOLE OVARIES OF CYNOMOLGUS MONKEYS AND RABBITS. Reprod Biomed Online 2010. [DOI: 10.1016/s1472-6483(10)62445-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
40
|
Usui N, Terada K, Baba K, Matsuda K, Nakamura F, Usui K, Tottori T, Umeoka S, Fujitani S, Mihara T, Inoue Y. P6-4 Very high frequency oscillations (over 1000 Hz) in human epilepsy. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60552-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Usui K. S39-6 Basal temporal language area. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60247-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
42
|
Versieren K, Heindryckx B, Qian C, Gerris J, De Sutter P, Exposito Navarro A, Ametzazurra A, Nagore D, Crisol L, Aspichueta F, Mendoza R, Matorras R, Garcia MM, Valley JK, Swinton PS, Boscardin WJ, Lue TF, P. Rinaudo, Wu MC, Bern O, Strassburger D, Komarovsky D, Kasterstein E, Komsky A, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Tang J, Fang C, Zhang MF, Li T, Zhuang GL, Suh DS, Joo JK, Choi JR, Kim SC, JO MS, Kim KH, Lee KS, Katz-Jaffe MG, Stevens J, McCormick S, Smith R, Schoolcraft WB, Ben-Ami I, Komsky A, Strassburger D, Bern O, Komarovsky D, Kasterstein E, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Koch J, Costello M, Kilani S, Namm A, Arend A, Aunapuu M, Joo JK, Lee KS, Choi YM, Cho JD, Sipe C, Pelts EJ, Matthews JM, Sanchez SR, Brohammer RLB, Wagner Y, Liebermann J, Uhler M, Beltsos A, Chen MJ, Guu HF, Chen YF, Yih YJ, Ho JYP, Lin TY, Ho ESC, Lopes FB, Figueira RCS, Braga DPAF, Ferreira RC, Aoki T, Iaconelli A, Borges E, Van de Velde H, Cauffman G, Verloes A, De Paepe C, Sterckx J, Van Ranst H, Devroey P, Tournaye H, Liebaers I, Santos MA, Teklenburg G, Macklon NS, Van Opstal D, Schuring-Blom GH, Krijtenburg PJ, de Vreeden-Elbertse J, Fauser BC, Baart EB, Cawood S, Doshi A, Gotts S, Serhal P, Milachich T, Petkova L, Barov D, Shterev A, Esteves TC, Balbach ST, Arauzo-Bravo MJ, Pfeiffer MJ, Boiani M, Le Gac S, van Rossem F, Esteves T, Bioani M, van den Berg A, Valeri C, Pappalardo S, De Felici M, Manna C, Ryu H, Park CY, Min SH, Choi SK, Park C, Lee SH, Kim KR, Jeong H, Chi HJ, Wittemer C, Celebi C, Viville S, Luceno Maestre F, Castilla Alcala JA, Gomez-Palomares JL, Cabello Y, Hernandez J, Marqueta J, Herrero J, Vidal E, Fernandez-Shaw S, Coroleu B, McRae C, Baskind E, Sharma V, Fisher J, Boldi Cotti P, Colasante C, Perego L, De Lauretis L, Montag M, Koster M, Nikolov A, van der Ven H, Lee SG, Lee YC, Kang SM, Kang YJ, Shin YK, Jung JH, Lim JH, Dorfmann A, Carroll K, Sisson M, Geltinger M, Yap S, Iwaszko M, Hara T, Naruse K, Matsuura K, Kodama T, Sato K, Tateaki Y, Tanaka J, Minasi MG, Scarselli F, Rubino P, Casciani V, Colasante A, Lobascio M, Alviggi E, Ferrero S, Litwicka K, Iammarrone E, Cucinelli F, Giannini PG, Tocci A, Nagy ZP, Greco E, Borini A, Tarozzi N, Fiorentin D, Bonu MA, Nadalini M, Johnson J, De Santis L, Bianchi V, Casciani V, Rubino P, Minasi MG, Colasante A, Scarselli F, Lobascio AM, Arizzi L, Iammarrone E, Litwicka K, Ferrero S, Tocci A, Piscitelli C, Cucinelli F, Nagy ZP, Greco E, Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M, Lee YM, Chen HW, Wu P, Tzeng CR, Antonova I, Milachich T, Petkova L, Yunakova M, Chaveeva P, A. Shterev, Hlinka D, Dudas M, Rutarova J, Rezacova J, Lazarovska S, Aoi Y, Takahashi H, Saitou H, Takiue C, Kawakami N, Tone M, Hirata R, Terada S, Yoshioka N, Habara T, Hayashi N, Montagut J, Bonald F, Guillen N, Guitard V, Balu-Genvrin E, Crae E, Nogueira D, Silva J, Cunha M, Viana P, Teixeira da Silva JM, Oliveira C, Goncalves A, Barros N, Sousa M, Barros A, van de Werken C, Jahr H, Laven JSE, Baart EB, Gamiz Izquierdo P, De los Santos JM, Tejera A, Pellicer A, Romero JL, Galan A, Albert C, Santos MJDL, Adriaenssens T, Wathlet S, Segers I, Verheyen G, Van De Velde H, Coucke W, Devroey P, Smitz J, Paternot G, D'Hooghe TM, Debrock S, Spiessens C, Hwang HK, Kim HM, Lee JH, Jung YJ, Kang A, Kook MJ, Jung JY, An SJ, Kwon HC, Lee SJ, Somova O, Feskov A, Feskova I, Chumakova N, Zozulina O, Zhilkova YE, Binda M, Campo R, Van Kerkhoven G, Frederickx V, Serneels A, Roziers P, Vranken I, Lopes AS, Van Nuland A, Gordts S, Puttemans P, Valkenburg M, Gordts S, Rodriguez-Arnedo A, Ten J, Guerrero J, Lledo B, Carracedo MA, Ortiz JA, Llacer J, Bernabeu R, Usui K, Nakajo Y, Ota M, Hattori H, Kyoya T, Takisawa T, Kyono K, Ferrieres A, Poulain M, Loup V, Anahory T, Dechaud H, Hamamah S, Eckert J, Premkumar G, Lock F, Brooks S, Haque S, Cameron IT, Cheong Y, Fleming TP, Prados N, Ruiz M, Garcia-Ortega J, Vime P, Hernaez MJ, Crespo M, Fernandez-Sanchez M, Pellicer A, Hashimoto S, Kato N, Saeki K, Morimoto Y, Leung CON, Pang RTK, Liu WM, Lee KF, Yeung WSB, Wada T, Elliott T, Kahn J, Lowderman J, Wright G, Chang C, Bernal D, Kort H, Nagy Z, de los Santos JM, Escrich L, Grau N, Pellicer A, Romero JL, Escriba MJ, Escriba M, Grau N, Escrich L, de los Santos JM, Pellicer A, Romero JL, Tasker F, Hamoda H, Wilner H, Grace J, Khalaf Y, Miyaji S, Mizuno S, Horiuchi L, Haruki A, Fukuda A, Morimoto Y, Utsunomiya T, Kumasako Y, Ito H, Goto K, Koike M, Abe H, Sakamoto T, Kojima F, Koshika T, Muzii L, Magli MC, Gioia L, Scaravelli G, Ferraretti AP, Gianaroli L, Capoti A, Magli MC, Lappi M, Maggi E, Ferraretti AP, Gianaroli L, Scott L, Finn A, Kloos B, Davies D, Yamada M, Hamatani T, Akutsu H, Chikazawa N, Ogawa S, Okumura N, Mochimaru Y, Kuji N, Aoki D, Yoshimura Y, Umezawa A, Aprysko VP, Yakovenko SA, Seregina EA, Yutkin EV, Yelke H, Milik S, Candan ZN, Altin G, Unal S, Atayurt Z, Y. Kumtepe, Chung JT, Son WY, Zhang X, Tan SL, Ao A, Seli E, Botros L, Henson M, Roos P, Judge K, Sakkas D, group MSGMS, Feliciano M, Monahan D, Ermolovich E, Rosenwaks Z, Palermo GD, Mantikou E, van Echten-Arends J, Sikkema-Raddatz B, van der Veen F, Repping S, Mastenbroek S, Botros L, Seli E, Henson M, Roos P, Judge K, Sakkas D, Group MBS, Wells V, Thum MY, Abdalla HI, Machiya R, Akimoto S, Nobuyoshi T, Yoshii N, Hosaka T, Odawara Y, Heindryckx B, Vanden Meerschaut F, Lierman S, Qian C, O'Leary T, Gerris J, De Sutter P, Assou S, Haouzi D, Pellestor F, Monzo C, Dechaud H, De Vos J, Hamamah S, Conaghan J, Fischer E, Popwell J, Ryan I, Chenette P, Givens C, Schriock E, Herbert C, Ermolovich E, Monahan D, Neri QV, Rosenwaks Z, Palermo GD, Verheyen G, Camus M, Van de Velde H, Haentjens P, Devroey P, Mugica A, Esbert M, Molina JM, Garrido N, Pellicer A, Ballesteros A, Calderon G, Rossi ALS, Rocha AM, Alegretti JR, Hassun PA, Gomes LP, Criscuollo T, Serafini P, Motta ELA, Munoz M, Meseguer M, Cruz M, Perez-Cano I, Pellicer A, Gadea B, Martinez M, Fortuno S, Gundersen J, Garrido N, Cruz M, Garrido N, Perez-Cano I, Munoz M, Pellicer A, Martinez M, Gadea B, Selles E, Betersen J, Meseguer M, Le Meaux E, Assou S, Haouzi D, Loup V, Dechaud H, De Vos J, Hamamah S, Ouandaogo G, Assou S, Haouzi D, Ferrieres A, Anahory T, De Vos J, Hamamah S, Monzo C, Assou S, Haouzi D, Pellestor F, Dechaud H, De Vos J, S. Hamamah, Gismano E, Borini A, Cino I, Calzi F, Rabellotti E, Papaleo E, Bianchi V, De Santis L, Sunkara SK, Siozos A, Bolton V, Khalaf Y, Braude P, El-Toukhy T, Cho YS, Ambruosi B, Totaro P, Dell'Aquila ME, Gioacchini G, Bizzaro D, Giorgini E, Ferraris P, Sabbatini S, Carnevali O, Knaggs P, Chau A, Khalil S, Trew G, Lavery S, Jovanovic VP, Gomez R, Sauer CM, Shawber CJ, Outtz HH, Wang X, Sauer MV, Kitajewski J, Zimmermann RC, Mahrous E, Clarke H, Virant-Klun I, Bacer-Kermavner L, Mivsek J, Tomazevic T, Pozlep B, Zorn B, Vrtacnik-Bokal E, Dundure I, Bazarova J, Fodina V, Brikune J, Lakutins J, Jee B, Jo J, Lee J, Suh C, Kim S, Moon S, Shufaro Y, Lebovich M, Aizenman E, Simon A, Laufer N, A. Saada Reisch, Ribeiro MA, Pinto A, Gomes F, Silva Carvalho JL, Almeida H, Massaro FC, Petersen CG, Mauri AL, Silva LFI, Nicoletti APM, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco JG, Valcarcel A, Viglierchio MI, Tiveron M, Guidobono M, Inza R, Vilela M, Vilela M, Valcarcel A, Viglierchio MI, Kenny A, Lombardi C, Marconi G. Posters * Embryology (Embryo Selection). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.140] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Matsumoto Y, Goto S, Hashimoto H, Kokeguchi S, Shiotani M, Okada H, Cohen - Bacrie P, Hazout A, Belloc S, De Mouzon J, Menezo Y, Dumont M, Junca AM, Cohen-Bacrie M, Alvarez S, Olivennes F, Prisant N, Weltin M, Geissler W, Clussmann C, Strowitzki T, Eggert-Kruse W, Endou Y, Fjii Y, Motoyama H, Quintana FQ, Zaloa Larreategui ZL, Iratxe Penalba IP, Sara Ortega SO, Monica Martin MM, Guillermo Quea GQ, Jose Serna JS, Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ, Zumoffen C, Munuce MJ, Caille A, Ghersevich S, Lendinez AM, Perez-Nevot B, Palomares AR, Serrano Garballo A, Rodriguez A, Reche A, Mayor-Olea A, Ruiz-Galdon M, Reyes-Engel A, Mendiola J, Jorgensen N, Andersson AM, Calafat AM, Redmon JB, Drobnis EZ, Wang C, Sparks A, Thurston SW, Liu F, Swan SH, Tarasconi AC, Tarasconi BV, Tarasconi DV, Silva EMV, Fujii Y, Endou Y, Motoyama H, Crha I, Pribyl J, Skladal P, Zakova J, Ventruba P, Pohanka M, De La Fuente G, Pacheco A, Velasco JAG, Requena A, Pacheco Castro A, San Celestino Carchenilla M, Salvanes R, Arnanz A, Balmori C, Pellicer A, Garcia-Velasco JA, Hashimoto H, Ishikawa T, Goto S, Kokeguchi S, Fujisawa M, Shiotani M, Kranz S, Hersemeyer K, Hentrich A, Tinneberg HR, Konrad L, Simon L, Lutton D, McManus J, Lewis SEM, San Celestino Carchenilla M, Pacheco Castro A, Rubio S, Simon Sanjurjo P, Pellicer A, Garcia-Velasco JA, Lewis S, Lutton D, McManus J, Simon L, Buzzi J, Valcarcel A, Lombardi E, Oses R, Rawe V, Young E, Magendzo A, Lizama S, Duque G, Mackenna A, Lutton D, Simon L, McManus J, Lewis SEM, Monqaut A, Zavaleta C, Lopez G, Lafuente R, Brassesco M, Condorelli R, La Vignera S, La Rosa S, Barone N, Vicari E, Bellanca S, D'Agata R, Calogero AE, Enciso M, Iglesias M, Galan I, Gosalvez A, Gosalvez J, Curaba M, Poels J, Van Langendonckt A, Donnez J, Wyns C, Garcez M, Salvador M, Pasqualotto EB, Braga DPAF, Borges E, Pasqualotto FF, Aoki T, Figueira RCS, Maldonado LGL, Pasqualotto FF, Iaconelli A, Borges E, Frassini R, Mandelli J, Pasqualotto EB, Borges E, Figueira RCS, Braga DPAF, Pasqualotto FF, Borges E, Pasqualotto FF, Figueira RCS, Setti AS, Braga DPAF, Cortezzi SS, Iaconelli A, La Vignera S, Vicari E, Di Mauro M, Burrello N, Condorelli R, D'Agata R, Calogero AE, Kashir J, Jones C, Young C, Ruas M, Grasa P, Rietdorf K, Heytens E, Heindryckx B, Yoon SY, Fissore RA, Deane CM, Nikiforaki D, Tee ST, de Sutter P, Parrington J, Coward K, Visser L, Westerveld GH, van Daalen SKM, van der Veen F, Lombardi MP, Repping S, Cubillos S, Sanchez S, Pedraza J, Charria G, Aparicio H, Gongora A, Caldino F, Cuneo S, Ou JP, Zhao WE, Liu YF, Xu YW, Zhou CQ, Al-Asmar Pinar N, Peinado V, Gruhn J, Susiarjo M, Gil-Salom M, Martinez-Jabaloyas JM, Pellicer A, Remohi J, Rubio C, Hassold T, Peinado V, Al-Asmar N, Gruhn J, Rodrigo L, Gil-Salom M, Martinez-Jabaloyas JM, Pellicer A, Remohi J, Hassold TJ, Rubio C, Bungum M, Forsell N, Giwercman A, Amiri I, Sheikh N, Najafi R, Godarzi M, Farimani M, Makukh H, Tyrkus M, Zastavna D, Nakonechnuy A, Khayat SS, Schileiko LV, Kurilo LF, Garcia-Herrero S, Garrido N, Martinez-Conejero JA, Romany L, Pellicer A, Meseguer M, Dorphin B, Lefevre M, Gout C, Oger P, Yazbeck C, Rougier N, De Stefani S, Scala V, Benedetti S, Tagliamonte MC, Zavagnini E, Palini S, Bulletti C, Canestrari F, Subiran N, Pinto FM, Candenas ML, Agirregoitia E, Irazusta J, Cha EM, Lee JH, Park IH, Lee KH, Kim MH, Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sorensen HT, Bonde JP, Henriksen TB, Olsen J, Bosco L, Speciale M, Manno M, Amireh N, Roccheri MC, Cittadini E, Wu P, Lee YM, Chen HW, Tzeng CR, Llacer J, Ten J, Lledo B, Rodriguez-Arnedo A, Morales R, Bernabeu R, Garcia-Peiro A, Martinez-Heredia J, Oliver-Bonet M, Ribas J, Abad C, Amengual MJ, Gosalvez J, Navarro J, Benet J, Moutou C, Gardes N, Nicod JC, Becker N, Bailly MP, Galland I, Pirello O, Rongieres C, Wittemer C, Viville S, Elmahaishi W, Smith B, Doshi A, Serhal P, Harper JC, Rennemeier C, Kammerer U, Dietl J, Staib P, Elgmati K, Nomikos M, Theodoridou M, Calver B, Swann K, Lai FA, Georgiou I, Lazaros L, Xita N, Kaponis A, Plachouras N, Hatzi E, Zikopoulos K, Ferfouri F, Clement P, Molina Gomes D, Albert M, Bailly M, Wainer R, Selva J, Vialard F, Takisawa T, Usui K, Kyoya T, Shibuya Y, Hattori H, Sato Y, Ota M, Kyono K, Chiu PC, Lam KK, Lee CL, Chung MK, Huang VW, O WS, Tang F, Ho PC, Yeung WS, Kim CH, Lee JY, Kim SH, Suh CS, Shin YK, Kang YJ, Jung JH, Cha CY, Hwang ES, Mukaida T, Nagaba M, Takahashi K, Elkaffash D, Sedrak M, Huhtaniemi I, Abdel-Al T, Younan D, Cassuto NG, Bouret D, Hammoud I, Yazbeck C, Barak Y, Seshadri S, Bates M, Vince G, Jones DI, Ben Khalifa M, Montjean D, Menezo Y, Cohen-Bacrie P, Belloc S, De Mouzon J, Alvarez S, Aubriot FX, Olivennes F, Cohen M, Prisant N, Boudjema E, Magli MC, Crippa A, Baccetti B, Ferraretti AP, Gianaroli L, Singer T, Neri QV, Hu JC, Maggiulli R, Kollman Z, Rauch E, Schlegel PN, Rosenwaks Z, Palermo GD, Zorn B, Skrbinc B, Matos E, Golob B, Pfeifer M, Osredkar J, Sabanegh E, Sharma RK, Thiyagarajan A, Agarwal A, Robin G, Boitrelle F, Marcelli F, Marchetti C, Mitchell V, Dewailly D, Rigot JM, Rives N, Perdrix A, Travers A, Milazzo JP, Mousset-Simeon N, Mace B, Jakab A, Molnar Z, Benyo M, Levai I, Kassai Z, Golob B, Zorn B, Ihan A, Kopitar A, Kolbezen M, Vaamonde D, Da Silva-Grigoletto ME, Garcia-Manso JM, Vaamonde-Lemos R, Oehninger SC, Walis G, Monahan D, Neri QV, Ermolovich E, Rosenwaks Z, Palermo GD, Fadlon E, Abu Elhija A, Abu Elhija M, Lunenfeld E, Huleihel M, Costantini-Ferrando M, Maggiulli R, Neri QV, Hu JCY, Monahan D, Rosenwaks Z, Palermo GD, Alvarez JG, Gosalvez A, Velilla E, Lopez-Teijon M, Lopez-Fernandez C, Gosalvez J, Tempest HG, Sun F, Oliver-Bonet M, Ko E, Turek P, Martin RH, Zomeno-Abellan MT, Ramirez A, Gutierrez-Adan A, Martinez JC, Landeras J, Ballesta J, Aviles M, Lafuente R, Lopez G, Monqaut A, Brassesco M, Ganaiem M, Binder S, Abu Elhija M, Lunenfeld E, Meinhardt A, Huleihel M, Sousa L, Grangeia A, Carvalho F, Sousa M, Barros A, Sifer C, Sermondade N, Hafhouf E, Poncelet C, Benzacken B, Levy R, Wolf JP, Crisol L, Aspichueta F, Hernandez ML, Exposito A, Matorras R, Ruiz-Larrea MB, Ruiz-Sanz JI, Jallad S, Atig F, Ben Amor H, Saad ALI, Kerkeni A, Ajina M, Othmane ALI, Koscinski I, Ladureau L, Wittemer C, Viville S, Scarselli F, Casciani V, Lobascio M, Minasi MG, Rubino P, Colasante A, Arizzi L, Litwicka K, Iammarrone E, Ferrero S, Mencacci C, Franco G, Zavaglia D, Nagy ZP, Greco E, Ohgi S, Takahashi M, Kishi C, Suga K, Yanaihara A, Chamley LW, Wagner A, Shelling AN. Andrology (Male Fertility, Spermatogenesis). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Talevi R, Barbato V, Mollo V, De Stefano C, Finelli F, Ferraro R, Gualtieri R, Zhou P, Liu AH, Cao YX, Roman H, Pura I, Tarta O, Bourdel N, Marpeau L, Sabourin JC, Portmann M, Nagy ZP, Behr B, Alvaro Mercadal B, Demeestere I, Imbert R, Englert Y, Delbaere A, Lueke S, Buendgen N, Koester F, Diedrich K, Griesinger G, Kim A, Han JE, Eunmi C, Kim YS, Cho JH, Yoon TK, Piomboni P, Stendardi A, Palumberi D, Morgante G, De Leo V, Serafini F, Focarelli R, Tatone C, Di Emidio G, Carbone MC, Vento M, Ciriminna R, Artini PG, Kyono K, Ishikawa T, Usui K, Hatori M, Yasmin L, Sato E, Iwasaka M, Fujii K, Owada N, Sankai T, McLaughlin M, Fineron P, Anderson RA, Wallace WHB, Telfer EE, Labied S, Beliard A, Munaut C, Foidart JM, Turkcuoglu I, Oktay K, Rodriguez-Wallberg K, Kuwayama M, Takayama Y, Mori C, Kagawa N, Akakubo N, Takehara Y, Kato K, Leibo SP, Kato O, Yoon H, Shin Y, cha J, Kim H, Lee W, Yoon S, Lim J, Larman MG, Gardner DK, Zander-Fox D, Lane M, Hamilton H, Oktay K, Lee S, Ozkavukcu S, Heytens E, Alappat RM, Sole M, Boada M, Biadiu M, Santalo J, Coroleu B, Barri PN, Veiga A, Rossi L, Bartoletti R, Mengarelli M, Boccia Artieri G, Gemini L, Mazzoli L, Giannini L, Scaravelli G, Kagawa N, Silber SJ, Kuwayama M, Yamanguchi S, Nagumo Y, Takai Y, Ishihara S, Takehara Y, Kato O, Lee S, Heytens E, Ozkavukcu S, Alappat RM, Oktay K, Soleimani R, Heytens E, Rottiers I, Gojayev A, Oktay K, Cuvelier AC, De Sutter P, Salama M, Winkler K, Murach KF, Hofer S, Wildt L, Friess SC, Okumura N, Kuji N, Kishimi A, Nishio H, Mochimaru Y, Minegishi K, Miyakoshi K, Fujii T, Tanaka M, Aoki D, Yoshimura Y, Hasegawa K, Juanzi S, Zhao W, Zhang S, Xue X, Silber S, Zhang J, Kuwayama M, Kagawa N, Meirow D, Gosden R, Westphal JR, Gerritse R, Beerendonk CCM, Braat DDM, Peek R, Coticchio G, Dal Canto M, Brambillasca F, Mignini Renzini M, Merola M, Lain M, Fadini R, Nottola SA, Albani E, Coticchio G, Lorenzo C, Carlini T, Maione M, Scaravelli G, Borini A, Macchiarelli G, Levi-Setti PE, Rienzi L, Romano S, Capalbo A, Iussig B, Albricci L, Colamaria S, Baroni E, Sapienza F, Giuliani M, Anniballo R, Ubaldi FM, Beyer DA, Schultze-Mosgau A, Amari F, Griesinger G, Diedrich K, Al-Hasani S, Resta S, Magli MC, Ruberti A, Lappi M, Ferraretti AP, Gianaroli L, Prisant N, Belloc S, Cohen-Bacrie M, Hazout A, Olivennes F, Aubriot FX, Alvarez S, De Mouzon J, Thieulin C, Cohen-Bacrie P, Wozniak S, Szkodziak P, Wozniakowska E, Paszkowski M, Paszkowski T, Diaz D, Nagy ZP, Dragnic S, Hayward B, Bennett R, Al-Sabbagh A, Novella-Maestre E, Teruel J, Carmona L, Rosello E, Pellicer A, Sanchez-Serrano M, Lee JR, Lee JY, Kim CH, Lee Y, Lee S, Jee BC, Suh CS, Kim SH, Moon SY, Sanchez-Serrano M, Novella-Maestre E, Teruel J, Mirabet V, Crespo J, Pellicer A, Schiewe M, Nugent N, Zozula S, Anderson R, Zulategui JF, Meseguer M, Pellicer A, Remohi J, Castello D, Romero JLL, De los Santos MJ, Cobo AC, von Wolff M, Jauckus J, Kupka M, Strowitzki T, Lawrenz B, Meirow D, Raanani H, Kaufman B, Maman E, Mendel MM, Dor J, Buendgen NK, Lueke S, Diedrich K, Griesinger G, Combelles C, Wang HY, Racowsky C, Kuleshova L, Tucker M, Graham J, Richter K, Carter J, Lim J, Levy M. Posters * Fertility Preservation. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Maemondo M, Sugawara S, Ishida T, Inoue A, Usui K, Ishimoto O, Matsubara N, Tachihara M, Saijo Y, Nukiwa T. Randomized phase II trial of tegafur-uracil (UFT) and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small cell lung cancer: NJLCG 0601. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
46
|
Ishimoto O, Sakakibara T, Maemondo M, Morikawa N, Okudera K, Usui K, Suzuki T, Inoue A, Nukiwa T, Sugawara S. Final results of a phase II trial of S-1 with biweekly docetaxel for non-small cell lung cancer previously treated with platinum-based chemotherapy (NJLCG0701). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
47
|
Inoue A, Ishimoto O, Fukumoto S, Usui K, Suzuki T, Yokouchi H, Maemondo M, Kanbe M, Ogura S, Harada T, Oizumi S, Harada M, Sugawara S, Fukuhara T, Nukiwa T. A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405. Ann Oncol 2010; 21:800-803. [DOI: 10.1093/annonc/mdp384] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Sakakibara T, Inoue A, Sugawara S, Maemondo M, Ishida T, Usui K, Abe T, Kanbe M, Watanabe H, Saijo Y, Nukiwa T. Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer. Ann Oncol 2009; 21:795-799. [PMID: 19815651 DOI: 10.1093/annonc/mdp401] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The optimal platinum doublet regimen in elderly patients with non-small-cell lung cancer (NSCLC) is still uncertain. We conducted a randomized phase II study to compare the efficacy and safety of weekly paclitaxel combined with carboplatin with those of the standard schedule. PATIENTS AND METHODS Elderly patients (age > or =70 years) with advanced NSCLC were randomly assigned to either the weekly arm {70 mg/m(2) paclitaxel on days 1, 8, and 15 and carboplatin [area under the curve (AUC) = 6] on day 1} or the standard arm [200 mg/m(2) paclitaxel and carboplatin (AUC = 6) on day 1]. The primary end point was the overall response rate (ORR). RESULTS Eighty-two patients were enrolled. The ORR and median progression-free survival were 55% and 6.0 months for the weekly arm and 53% and 5.6 months for the standard arm. Grade 3/4 neutropenia and peripheral neuropathy were observed in 41% and 0% of the patients in the weekly arm and in 88% and 25% in the standard arm, respectively. CONCLUSIONS This is the first randomized study that compares the platinum doublet designed specifically for the elderly. Regarding the safety, the weekly regimen was less toxic than the standard regimen and seems to be preferable for elderly patients with advanced NSCLC.
Collapse
Affiliation(s)
- T Sakakibara
- Department of Respiratory Medicine, Tohoku University Hospital.
| | - A Inoue
- Department of Respiratory Medicine, Tohoku University Hospital
| | - S Sugawara
- Department of Respiratory Medicine, Sendai Kousei Hospital, Sendai
| | - M Maemondo
- Department of Respiratory Medicine, Miyagi Cancer Center, Natori
| | - T Ishida
- Department of Respiratory Medicine, Fukushima Medical University Hospital, Fukushima
| | - K Usui
- Department of Respiratory Medicine, Kanto Medical Center NTT EC, Shinagawa-ku, Tokyo
| | - T Abe
- Department of Respiratory Medicine, Tohoku Kouseinenkin Hospital, Sendai
| | - M Kanbe
- Department of Respiratory Medicine, Senseki Hospital, Higashimatsushima, Yamoto
| | - H Watanabe
- Department of Respiratory Medicine, Saka General Hospital, Shiogama
| | - Y Saijo
- Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - T Nukiwa
- Department of Respiratory Medicine, Tohoku University Hospital
| |
Collapse
|
49
|
Maemondo M, Ishimoto O, Inoue A, Matsubara N, Morikawa N, Okudera K, Usui K, Suzuki T, Nukiwa T, Sugawara S. 9070 Phase II trial of S-1 with bi-weekly docetaxel for non-small-cell lung cancer previously treated with platinum-based chemotherapy: a North Japan Lung Cancer Study Group (NJLCG0701). EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71783-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
50
|
Ishimoto O, Inoue A, Sugawara S, Harada M, Usui K, Suzuki T, Yokouchi H, Maemondo M, Nukiwa T. Final result of phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for elderly patients with small cell lung cancer (SCLC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.8054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8054 Background: AMR, a new anthracycline agent, is active for SCLC. We had previously reported a phase I study of AMR combined with CBDCA for elderly patients with SCLC (J Thorac Oncol 1:551, 2006). The objective of this study is to evaluate the efficacy and the safety of this combination for elderly patients with SCLC. Methods: Chemotherapy naïve elderly patients (70 years or older) with SCLC received AMR (35 mg/m2, day1–3) and CBDCA (AUC 4.0, day1) every 3 weeks. The primary endpoint was overall response rate (ORR), and secondary endpoints were progression-free survival (PFS), overall survival and toxicity profile. Assuming that ORR of 60% in eligible pts would indicate potential usefulness while ORR of 40% would be the lower limit of interest, with alpha = 0.10 and beta = 0.20, the estimated accrual was 30 patients. Results: From January 2005 to November 2007, 36 pts were enrolled from 11 institutions. Patient characteristics were: Male/Female 27/9; median age 76 (range 70–83); Performance status 0/1 17/19. The median numbers of treatment cycles were 4 (range 2–7). The objective responses were CR 1, PR 31, SD 2, PD 2, and the ORR was 89%. Median PFS was 5.8 months and median survival time was 18.6 months. Grade 3–4 neutropenia was observed in all the patients and 5 patients (14%) suffered from grade 3–4 febrile neutropenia. Other toxicities were moderate and no treatment related death was observed. Conclusions: AMR combined with CBDCA is quite effective for SCLC with acceptable toxicities even for the elderly population. Further evaluation of this regimen is warranted. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- O. Ishimoto
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - A. Inoue
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - S. Sugawara
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - M. Harada
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - K. Usui
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - T. Suzuki
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - H. Yokouchi
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - M. Maemondo
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| | - T. Nukiwa
- Sendai Kousei Hospital, Sendai, Japan; Tohoku University Hospital, Sendai, Japan; Hokkaido Cancer Center, Sapporo, Japan; Kanto Medical Center NTT-EC, Tokyo, Japan; Isawa Hospital, Isawa, Japan; Iwamizawa Rosai Hospital, Iwamizawa, Japan; Miyagi Cancer Center, Natori, Japan
| |
Collapse
|